CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HEPI Pharmaceuticals, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HEPI Pharmaceuticals, Inc.
7740 E Evans Rd Ste A100
Phone: (480) 385-3800p:480 385-3800 SCOTTSDALE, AZ  85260-3410  United States
Business Summary
HEPI Pharmaceuticals, Inc. is a development stage company. The Company is focused on developing pharmaceutical applications of ProAlgaZyme(PAZ). The Company is wholly owned subsidiary of Health Enhancement Products, Inc. (HEPI). PAZ is HEPI’s sole product. ProAlgaZyme is a liquid product derived from a natural plant culture grown in purified water with feeding. The Company focuses to isolate the active ingredients in ProAlgaZyme and manufacture this product in pharmaceutical form.
(Source: 10KSB)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 IRA CQ
Score		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes------

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/200812/31/2007YesYes---

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Interim Chief Executive Officer PeterVitulli 9/8/2009 9/8/2009
Interim Principal Administrative Officer, Principal Accounting Officer (Part-Time), Treasurer, Dire Janet L.Crance 54 9/1/2007 1/10/2007
Secretary, Director JohnGorman 44 1/10/2007

General Information
Outstanding Shares: 100 (As of 9/30/2008)
Federal Tax Id: 208282461


Copyright © 2020 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, May 16, 2020